These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 28796540)
1. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. Zamanlu M; Farhoudi M; Eskandani M; Mahmoudi J; Barar J; Rafi M; Omidi Y J Drug Target; 2018 Feb; 26(2):95-109. PubMed ID: 28796540 [TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke. Liu S; Feng X; Jin R; Li G Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694 [TBL] [Abstract][Full Text] [Related]
3. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172 [TBL] [Abstract][Full Text] [Related]
4. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Eissa A; Krass I; Bajorek BV J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke. Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354 [TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis for acute ischemic stroke in Asia. Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676 [TBL] [Abstract][Full Text] [Related]
14. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773 [TBL] [Abstract][Full Text] [Related]
15. The use and misuse of thrombolytic therapy within the Veterans Health Administration. Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924 [TBL] [Abstract][Full Text] [Related]
16. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Weintraub MI Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683 [TBL] [Abstract][Full Text] [Related]
17. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care. Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183 [TBL] [Abstract][Full Text] [Related]
18. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study. Shi J; Peng H; You S; Liu Y; Xu J; Xu Y; Liu H; Shi R; Cao Y; Liu CF Eur J Neurol; 2018 Apr; 25(4):687-e45. PubMed ID: 29341345 [TBL] [Abstract][Full Text] [Related]
19. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797 [TBL] [Abstract][Full Text] [Related]